Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
about
Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylasemiR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinomaHepatitis B Virus X Protein and HepatocarcinogenesisHepatocellular carcinoma: Where are we?CRISPR/Cas9 and cancer targets: future possibilities and present challengesEGFR Signaling in Liver DiseasesGenetic variation of hepatitis B virus and its significance for pathogenesisMolecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesisHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsProgress and Prospects of Anti-HBV Gene Therapy DevelopmentNutrition and metabolism in hepatocellular carcinomaHepatitis B virus, HBx mutants and their role in hepatocellular carcinomaInhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinomaEag1 channels as potential early-stage biomarkers of hepatocellular carcinomaCharacterization of a Novel Hepadnavirus in the White Sucker (Catostomus commersonii) from the Great Lakes Region of the United StatesIntegration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomasVirtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancerViruses and human cancers: a long road of discovery of molecular paradigms.Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesGlobal gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerC-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytesIdentification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern ChinaCreation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line.The hepatitis B virus x protein inhibits thymine DNA glycosylase initiated base excision repairDistinct Viral Lineages from Fish and Amphibians Reveal the Complex Evolutionary History of Hepadnaviruses.Cullin E3 ligases and their rewiring by viral factorsThe hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.The CRISPR/Cas9 genome editing methodology as a weapon against human virusesEpigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.Robust sequence alignment using evolutionary rates coupled with an amino acid substitution matrixDownregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literatureTP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The GambiaTGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.
P2860
Q21089944-364FDE3E-363F-49C2-90EF-8638EE84F105Q24658453-90620AAA-950C-4BD6-8D96-FB8034F7F16FQ26744503-2EC1BACF-0D5A-40A8-8D7B-4C0A011D5881Q26765182-43C4BDCF-F33F-43F9-B963-DA9AB695234EQ26769907-C7A195F4-DF34-4514-8998-E8FD17C59591Q26771265-F074BA7F-CF6B-438A-B4ED-62E9B28297BEQ26772348-BEA271DE-221F-4A83-BF9E-79A328C82B3BQ26782044-C44B56B4-3C29-48BF-A35A-C02843890B9CQ26783881-97AD155C-678B-465B-A8F3-776121C5A046Q26799228-2D99B24A-BD35-4079-9962-552D561625C6Q26862862-5605C8CD-DCBF-4483-97A5-B7D4D9E8EF96Q27024874-EC141707-A67B-45C0-8F22-12CB030CEC19Q28068512-1F6ECCB0-87F0-40D7-B825-EF0DD351D08CQ28069313-ED94F5CE-1C44-43C3-B58E-77A89413010BQ28607462-F5020272-2392-459D-A3C5-E816D493F4AEQ28649881-EEF9EEB9-6F45-4240-822F-6B64A9F670F4Q30366407-B0F43439-36D9-4D1E-92BE-ED788FB33297Q30384388-EB2A9544-BBE4-42E9-AAF4-F3B5128A6F84Q30570945-FFA42D33-88D4-4E98-9355-E3C1C86CE331Q31113966-52CCBF3F-819D-40A9-B3CD-D8AE653C2A38Q33618740-E93D60B3-B14B-42D9-B92B-CCA7BC57282FQ33689008-BD5DDB78-8A21-4193-B6BF-F96BD5DC3883Q33873291-47AA51E7-3757-4673-B09A-CF88E84426A4Q34308946-A9EAD8BE-7B6A-4C14-A902-7E6804173C60Q34371513-6040C006-A409-4D0D-AE8C-8F78F402FF72Q34435683-A731A8BF-2D70-4291-8087-E084CE7D40B3Q34473782-96D2A395-F743-4D36-870A-F17E2BDD0AD5Q34531745-FC605E9E-958A-4873-931A-3D3713B38CB3Q34785767-25BF4B83-7122-435F-9E7A-984969D5EFC2Q35136610-DE3028A7-FBC8-4536-B137-C39FD222F276Q35654689-5BE09240-56B9-4D4A-B375-0084EC669B62Q35666404-62DE1DBB-3FA1-411D-9F74-2AC1865B03DDQ35744639-22BDBB80-3FEB-4A25-B630-4B9F8223D62CQ35826547-BCD6CEDE-115B-44C8-870F-AF028A6E6169Q35883937-FE4366CE-BD41-4117-B058-3DB48593F654Q35893922-E78A5D41-39C8-4ED5-A9D5-DD007D5B7843Q35978719-DE7448C7-EC61-451C-964F-A0600058224EQ36052356-6E789299-347E-461A-8860-05C044334943Q36072589-EC918A53-9FD6-448A-8E6D-8AED46A00C82Q36237549-E0FA4BA5-3D22-4CB4-B7D4-E35DE80677D9
P2860
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@ast
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@en
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@nl
type
label
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@ast
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@en
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@nl
prefLabel
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@ast
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@en
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@nl
P2860
P1476
Hepatitis B virus x protein in ...... uced hepatocellular carcinoma.
@en
P2093
Michael C Kew
P2860
P304
P356
10.1111/J.1440-1746.2010.06546.X
P478
26 Suppl 1
P577
2011-01-01T00:00:00Z